News

A pretrained artificial intelligence model demonstrates a high sensitivity in detecting pancreatic cancer on CT scans, a new ...
Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and challenges shaping SMMT's future.
Shares of Liminatus Pharma rose after the company shared plans to collaborate on developing a diagnostic kit for detecting pancreatic cancer. The stock advanced 3.7%, to $9.35, in after-hours trading ...
A compound best known for giving almonds and apricots their aroma may be the key to defeating hard-to-kill cancer cells. Japanese researchers found that benzaldehyde can stop the shape-shifting ...
The Glasgow, Scotland-based firm's Panaromic Platform uses an infrared spectroscopy-based test with machine learning-developed algorithms to detect signals of cancer.
A similarly gloomy simulation posted by Dr Paulien Moyaert back in May documented how being diagnosed with cancer can lead to ...
MRI-based screening has the potential for identifying early-stage pancreatic cancer in older adults with new onset or deteriorating diabetes, preliminary results show.
Melissa Gilbert is reflecting on the lasting impression left by Michael Landon, 34 years after his death. On Tuesday, July 1, ...
Using 400 real-world patient cases, the CARE platform correctly classified 99.5 percent of cases according to NCCN guidelines ...
Pro Football Hall of Famer Randy Moss was noticeably absent from several broadcasts of ESPN's long-running "Sunday NFL ...
During therapy, some cancer cells evolve to escape elimination. Newer anticancer drugs that can overcome this resistance are necessary. Now, researchers from Japan demonstrate that aromatic ...
During therapy, some cancer cells evolve to escape elimination. Newer anticancer drugs that can overcome this resistance are ...